PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma.
Multiple myeloma
PET/CT
Staging
Journal
PET clinics
ISSN: 1879-9809
Titre abrégé: PET Clin
Pays: United States
ID NLM: 101260152
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
entrez:
16
5
2019
pubmed:
16
5
2019
medline:
24
12
2019
Statut:
ppublish
Résumé
In the past decade novel treatment options have dramatically prolonged the survival of patients with multiple myeloma. PET combined with computed tomography (CT) is a sensitive and reliable functional imaging tool that enables diagnosis and assessment of response to chemotherapy/radiotherapy, and combines high sensitivity in identifying both lytic lesions and extramedullary soft-tissue masses with the ability to provide reliable prognostic information in the management of patients with myeloma. This review comprises a comprehensive overview of PET with fluorodeoxyglucose F 18/CT imaging in combination with other convenient imaging procedures, and attempts at standardization with emphasis on post-therapy findings in patients with myeloma.
Identifiants
pubmed: 31084776
pii: S1556-8598(19)30025-2
doi: 10.1016/j.cpet.2019.03.009
pii:
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
369-381Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.